Loading…
Ardent Health, Inc. is projected to rise to $14.74 by 2027, a +38% move from its current price of $10.67. ARDT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $10.42 | $10.68 | $10.94 | +0.06% |
| Aug 3 | $10.33 | $10.68 | $11.05 | +0.13% |
| Aug 4 | $10.26 | $10.69 | $11.14 | +0.19% |
| Aug 5 | $10.20 | $10.70 | $11.22 | +0.26% |
| Aug 6 | $10.15 | $10.70 | $11.29 | +0.32% |
| Aug 7 | $10.10 | $10.71 | $11.36 | +0.39% |
| Aug 8 | $10.06 | $10.72 | $11.42 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.06 | $10.72 | $11.42 | +0.45% |
| Week 2 | $9.84 | $10.77 | $11.77 | +0.90% |
| Week 3 | $9.69 | $10.81 | $12.07 | +1.35% |
| Week 4 | $9.57 | $10.86 | $12.33 | +1.81% |
| Week 5 | $9.47 | $10.91 | $12.57 | +2.27% |
| Week 6 | $9.39 | $10.96 | $12.80 | +2.73% |
| Week 7 | $9.31 | $11.01 | $13.02 | +3.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings.
It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers.
Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Ardent Health, Inc. (ARDT) trades at $10.95 per share and has a market capitalization of $1.57B. It ranks 2104 among listed companies by market cap.
The near-term price environment shows bullish signals, with a current price near a technical setup that supports upside potential and a chart structure that aligns with the bullish sentiment.
The stock’s 30-day range is $9.44 to $12.71, and its annualized volatility sits at 40%, indicating a relatively wide trading band over the period.
A major floor 27.0% below — a decisive break under it would weaken the trend.
The nearest floor, 16.5% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 21.0% above — clearing it would confirm fresh momentum.
Key ARDT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.95 | Sell | $10.79 | Sell |
| MA 10 | $10.71 | Sell | $10.69 | Sell |
| MA 20 | $10.45 | Buy | $10.45 | Buy |
| MA 50 | $9.77 | Buy | $10.04 | Buy |
| MA 100 | $9.59 | Buy | $9.86 | Buy |
| MA 200 | $9.89 | Buy | $10.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.04 | Neutral |
| Stoch RSI (14) | 27.21 | Neutral |
| CCI (20) | 42.52 | Neutral |
| Williams %R (14) | -47.90 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 8.88 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 52.10 | Neutral |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 0.88 | Buy |
| Ultimate (7,14,28) | 59.39 | Neutral |
| Momentum (10) | 0.52 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 10.99 | Sell |
| ADX (14) | 17.90 | Neutral |
| ATR (14) | 0.22 | Info |
The near-term technical picture is bullish, with RSI14 at 70. Prices are above the SMA50 of $9.70 and the SMA200 of $9.96, suggesting upside momentum.
Support is at $8.91 and resistance at $10.95, framing a constructive short-term path for price action. The 30-day range spans from $9.44 to $12.71, illustrating a workable swing zone for the stock in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.83 | $10.67 | $14.51 | 0% | Neutral | |
| $11.89 | $14.74 | $19.24 | +38% | Bullish | |
| $12.05 | $15.32 | $20.67 | +44% | Bullish | |
| $13.38 | $17.35 | $24.04 | +63% | Bullish | |
| $15.10 | $19.93 | $28.22 | +87% | Bullish | |
| $16.27 | $21.81 | $31.49 | +104% | Bullish | |
| $20.54 | $27.95 | $41.07 | +162% | Bullish | |
| $23.03 | $31.78 | $47.42 | +198% | Bullish | |
| $24.17 | $33.79 | $51.16 | +217% | Bullish | |
| $26.55 | $37.60 | $57.69 | +252% | Bullish | |
| $40.67 | $60.94 | $98.91 | +471% | Bullish | |
| $74.06 | $122.14 | $215.29 | +10.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.83 | $10.67 | $12.85 | +0.00% |
| September 2026 | $9.46 | $11.15 | $13.49 | +4.50% |
| October 2026 | $9.54 | $11.31 | $13.81 | +1.45% |
| November 2026 | $9.49 | $11.31 | $13.92 | -0.02% |
| December 2026 | $9.78 | $11.71 | $14.51 | +3.52% |
Click any year to see its month-by-month ARDT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ARDT to range from $7.83 to $14.51 through 2026. The $10.67 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ARDT price prediction for 2027 points to an average of $14.74 (low $11.89, high $19.24) — a potential gain of +38% on today's $10.67. Buyers look set to stay in control over this stretch.
In 2028, ARDT is projected to trade between $12.05 and $20.67, averaging $15.32 — a potential gain of +44% from today's $10.67. That is up +4% on the projected 2027 average. Momentum favours further upside here.
Ardent Health, Inc.'s 2029 outlook centres on $17.35, within a $13.38 to $24.04 range. That is up +13% on the projected 2028 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ARDT could reach as high as $28.22, with a base case around $19.93 and support toward $15.10 — roughly +87% from $10.67. Momentum favours further upside here.
Expect ARDT to range from $16.27 to $31.49 through 2031. The $21.81 average target implies a +104% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ARDT price prediction for 2032 points to an average of $27.95 (low $20.54, high $41.07) — a potential gain of +162% on today's $10.67. Momentum favours further upside here.
In 2033, ARDT is projected to trade between $23.03 and $47.42, averaging $31.78 — a potential gain of +198% from today's $10.67. That is up +14% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Ardent Health, Inc.'s 2034 outlook centres on $33.79, within a $24.17 to $51.16 range. That is up +6% on the projected 2033 average. That marks a +217% change versus current levels. Momentum favours further upside here.
By 2035, ARDT could reach as high as $57.69, with a base case around $37.60 and support toward $26.55 — roughly +252% from $10.67. Buyers look set to stay in control over this stretch.
Expect ARDT to range from $40.67 to $98.91 through 2040. The $60.94 average target implies a +471% move from current prices. That is up +62% on the projected 2035 average. Momentum favours further upside here.
The ARDT price prediction for 2050 points to an average of $122.14 (low $74.06, high $215.29) — a potential gain of +10.4x on today's $10.67. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDT today (≈ 93.720712 ARDT) could be worth
$11,447.04
+$10,447.04 (+1045%) by 2050 · US Dollar
Based on the average projected ARDT price of $122.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDTwould be worth at today's price.
$1,000 invested in ARDT on Jul 31, 2025 (≈ 94.339619 ARDT) would be worth
$1,006.6
+$6.6 (+0.7%) today · 1.01× · US Dollar
Based on a ARDT entry price of $10.6 vs. today's $10.67.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.64 | $1,002.82 | +0.3% |
| 1 month ago | $10.13 | $1,053.31 | +5.3% |
| 3 months ago | $10.15 | $1,051.23 | +5.1% |
| 6 months ago | $8.59 | $1,242.14 | +24.2% |
| 1 year ago | $10.6 | $1,006.6 | +0.7% |
| All time (2.0y) ago | $16.06 | $664.38 | -33.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDT forecast.
Our base-case forecast reaches $21.00 around 2031.
Implied market cap at $21.00: $3.01B
Forecasts project a clear bullish trajectory over the coming years, with 2026 expected to average $10.95 (min $7.83, max $14.89) and an implied 0% ROI, signaling a neutral stance for that year.
By 2030, the average forecast rises to $20.13 with an 83.8% ROI, and the sentiment remains bullish. The path continues with 2040 at $59.59 average and a 444.2% ROI, then 2050 at $119.21 average and a 988.7% ROI, all within a bullish framework despite inherent uncertainty.
These figures are estimates reflecting market conditions over time and are not guaranteed. While the longer-horizon outlook is strongly positive, shorter-horizon results can vary with volatility and external factors.
Tap a question to reveal the answer.
Average forecast is $20.13 with a min of $15.38 and a max of $28.22, and an ROI of 83.8%; sentiment is BULLISH.
The forecast shows a bullish trajectory after 2026, with higher average prices in 2030, 2040, and 2050 and positive ROIs (83.8% in 2030, 444.2% in 2040, 988.7% in 2050), but 2026 is Neutral and outcomes are not guaranteed.
The 2040 forecast shows an average price of $59.59, with a 444.2% ROI, indicating a path toward the low $60s in that horizon.
Current price is $10.95 per share and market capitalization is $1.57B.
Average forecast is $119.21 with a min of $74.05 and a max of $206.09, and an ROI of 988.7%; sentiment is BULLISH.
Ardent Health, Inc. Community Discussion
0Share your Ardent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.